Terms: = Liver cancer AND MAP2K1, MAPKK1, 5604, ENSG00000169032, Q02750, MEK1, MKK1, PRKMK1 AND Prognosis
16 results:
1. CENPL accelerates cell proliferation, cell cycle, apoptosis, and glycolysis via the mek1/2-ERK1/2 pathway in hepatocellular carcinoma.
He K; Xie M; Hong W; Li Y; Yin Y; Gao X; He Y; Chen Y; You C; Li J
Int J Biochem Cell Biol; 2024 Jan; 166():106481. PubMed ID: 37914022
[TBL] [Abstract] [Full Text] [Related]
2. Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term prognosis in a high-volume center.
Zhang XP; Xu S; Zhao ZM; Liu Q; Zhao GD; Hu MG; Tan XL; Liu R
Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):140-146. PubMed ID: 36171169
[TBL] [Abstract] [Full Text] [Related]
3. ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma.
Wang Y; Zhang Y; Mi J; Jiang C; Wang Q; Li X; Zhao M; Geng Z; Song X; Li J; Zuo L; Ge S; Zhang Z; Wen H; Wang Z; Su F
Oncogene; 2022 Jul; 41(29):3680-3693. PubMed ID: 35725908
[TBL] [Abstract] [Full Text] [Related]
4. A linkage between effectual genes in progression of CRC through canonical and non-canonical TGF-β signaling pathways.
Shirin M; Madadi S; Peyravian N; Pezeshkian Z; Rejali L; Hosseini M; Moradi A; Khanabadi B; Sherkat G; Aghdaei HA; Nazemalhosseini-Mojarad E
Med Oncol; 2022 Jan; 39(4):40. PubMed ID: 35092502
[TBL] [Abstract] [Full Text] [Related]
5. CircNFIB inhibits tumor growth and metastasis through suppressing mek1/ERK signaling in intrahepatic cholangiocarcinoma.
Du J; Lan T; Liao H; Feng X; Chen X; Liao W; Hou G; Xu L; Feng Q; Xie K; Liao M; Chen X; Huang J; Yuan K; Zeng Y
Mol Cancer; 2022 Jan; 21(1):18. PubMed ID: 35039066
[TBL] [Abstract] [Full Text] [Related]
6. Clinical study of map2k1-mutated Langerhans cell histiocytosis in children.
Yang Y; Wang C; Wang D; Cui L; Li N; Lian H; Ma H; Zhao Y; Zhang L; Liu W; Wang Y; Wu W; Zhang R; Li Z; Wang T
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2517-2527. PubMed ID: 34595543
[TBL] [Abstract] [Full Text] [Related]
7. Computational Analysis of Cholangiocarcinoma Phosphoproteomes Identifies Patient-Specific Drug Targets.
Khorsandi SE; Dokal AD; Rajeeve V; Britton DJ; Illingworth MS; Heaton N; Cutillas PR
Cancer Res; 2021 Nov; 81(22):5765-5776. PubMed ID: 34551960
[TBL] [Abstract] [Full Text] [Related]
8. Integrative pan-cancer analysis of mek1 aberrations and the potential clinical implications.
Zhou Z; Peng B; Li J; Gao K; Cai Y; Xu Z; Yan Y
Sci Rep; 2021 Sep; 11(1):18366. PubMed ID: 34526571
[TBL] [Abstract] [Full Text] [Related]
9. GINS2 promotes EMT in pancreatic cancer via specifically stimulating ERK/MAPK signaling.
Huang L; Chen S; Fan H; Ji D; Chen C; Sheng W
Cancer Gene Ther; 2021 Aug; 28(7-8):839-849. PubMed ID: 32747685
[TBL] [Abstract] [Full Text] [Related]
10. CircDLST promotes the tumorigenesis and metastasis of gastric cancer by sponging miR-502-5p and activating the NRAS/mek1/ERK1/2 signaling.
Zhang J; Hou L; Liang R; Chen X; Zhang R; Chen W; Zhu J
Mol Cancer; 2019 Apr; 18(1):80. PubMed ID: 30953514
[TBL] [Abstract] [Full Text] [Related]
11. Demethylation-Induced Overexpression of Shc3 Drives c-Raf-Independent Activation of MEK/ERK in HCC.
Liu Y; Zhang X; Yang B; Zhuang H; Guo H; Wei W; Li Y; Chen R; Li Y; Zhang N
Cancer Res; 2018 May; 78(9):2219-2232. PubMed ID: 29330146
[TBL] [Abstract] [Full Text] [Related]
12. Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression.
De Smedt E; Maes K; Verhulst S; Lui H; Kassambara A; Maes A; Robert N; Heirman C; Cakana A; Hose D; Breckpot K; van Grunsven LA; De Veirman K; Menu E; Vanderkerken K; Moreaux J; De Bruyne E
Cancer Res; 2018 Mar; 78(5):1155-1168. PubMed ID: 29259009
[TBL] [Abstract] [Full Text] [Related]
13. BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via mek1/ERK/ELK1 signaling in hepatocellular carcinoma.
Ma J; Zeng S; Zhang Y; Deng G; Qu Y; Guo C; Yin L; Han Y; Cai C; Li Y; Wang G; Bonkovsky HL; Shen H
Cancer Lett; 2017 Dec; 411():117-129. PubMed ID: 28987388
[TBL] [Abstract] [Full Text] [Related]
14. Ectopic overexpression of filamin C scaffolds mek1/2 and ERK1/2 to promote the progression of human hepatocellular carcinoma.
Yang B; Liu Y; Zhao J; Hei K; Zhuang H; Li Q; Wei W; Chen R; Zhang N; Li Y
Cancer Lett; 2017 Mar; 388():167-176. PubMed ID: 27919788
[TBL] [Abstract] [Full Text] [Related]
15. Pinin associates with prognosis of hepatocellular carcinoma through promoting cell proliferation and suppressing glucose deprivation-induced apoptosis.
Yang X; Sun D; Dong C; Tian Y; Gao Z; Wang L
Oncotarget; 2016 Jun; 7(26):39694-39704. PubMed ID: 27175589
[TBL] [Abstract] [Full Text] [Related]
16. Expression and prognostic role of pan-Ras, Raf-1, pmek1 and pERK1/2 in patients with hepatocellular carcinoma.
Chen L; Shi Y; Jiang CY; Wei LX; Wang YL; Dai GH
Eur J Surg Oncol; 2011 Jun; 37(6):513-20. PubMed ID: 21324414
[TBL] [Abstract] [Full Text] [Related]
